Psychiatry and Neurology, Neurology · Harrisburg, PA
NPI
1275749335
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4310 Londonderry Rd Ste 202
Harrisburg, PA, 17109
Phone (717) 920-7664
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
3,506 services
Medicare patients, 2024
154
Average age 70
Drug cost, 2024
$1.1M
444 prescriptions
Company payments, 2025
$283
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mamta Verma was code 95886 (electrical nerve conductivity), 132 times for 77 patients. In total Mamta Verma billed 3,506 services in 24 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Office | 132 | 77 | $70.65 | $9,326 |
| 99214 Office E&M - Established | Office | 68 | 45 | $75.78 | $5,153 |
| 95910 Electrical Nerve Conductivity | Office | 32 | 32 | $123.66 | $3,957 |
| 99204 Office E&M - New | Office | 21 | 21 | $100.40 | $2,108 |
| 95912 Electrical Nerve Conductivity | Office | 15 | 15 | $158.26 | $2,374 |
| 95913 Electrical Nerve Conductivity | Office | 15 | 15 | $213.75 | $3,206 |
| 95911 Electrical Nerve Conductivity | Office | 11 | 11 | $144.16 | $1,586 |
By year: 2022 $40K for 2,342 services; 2023 $41K for 2,936 services; 2024 $50K for 3,506 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mamta Verma prescribed most often to Medicare patients was Gabapentin, with 61 prescriptions and refills. In total Mamta Verma wrote 444 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 61 | 122 | 18 | $1,445 |
| Baclofen Generic | 34 | 63 | 11 | $724 |
| Dalfampridine Er Dalfampridine | 32 | 34 | Under 11 | $29K |
| Tizanidine Hcl Generic | 30 | 56 | Under 11 | $502 |
| Plegridy Pen Peginterferon Beta-1a | 23 | 23 | Under 11 | $181K |
| Cyclobenzaprine Hcl Generic | 20 | 20 | Under 11 | $37.72 |
| Dimethyl Fumarate Generic | 18 | 18 | Under 11 | $54K |
| Modafinil Generic | 18 | 18 | Under 11 | $625 |
| Pyridostigmine Bromide Generic | 14 | 28 | Under 11 | $12K |
| Copaxone Glatiramer Acetate | 14 | 14 | Under 11 | $80K |
| Prednisone Generic | 14 | 15 | Under 11 | $41.26 |
| Mycophenolate Mofetil Generic | 14 | 24 | Under 11 | $1,070 |
| Amitriptyline Hcl Generic | 14 | 32 | Under 11 | $184 |
| Botox Onabotulinumtoxina | 11 | 31 | Under 11 | $34K |
Brand drugs: 88 claims; generic drugs: 356 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mamta Verma $283 ($283 in general payments such as food, travel and fees) from 6 companies. The largest payer was Ipsen Biopharmaceuticals, Inc with $133.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.